- Publication
- Jun 16, 2023
Atomistic simulations of the Escherichia coli ribosome provide selection criteria for translationally active substrates
Zoe L. Watson, et al. Nature Chemistry, 2023- Publication
- Feb 16, 2023
Structure-based assessment and druggability classification of protein-protein interaction sites
Lara Alzyoud, et al. Scientific Reports, 2023, 12, 7975- Publication
- Feb 16, 2023
A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model
Davide Tavella, et al. PLoS ONE, 2022, 17(12)- Publication
- May 2, 2022
Accurate Prediction of Protein Thermodynamic Stability Changes upon Residue Mutation using Free Energy Perturbation
Guido Scarabelli, et al. JMB, 2022, 434(2)- Publication
- Jul 6, 2021
Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations
Dana Katz, et al. Marine Drugs, 2021, 19(7), 367- Publication
- Jan 30, 2020
GemSpot: A Pipeline for Robust Modeling of Ligands into CryoEM Maps
Robertson, et al. bioRxiv, 2019, 750778, Preprint- Publication
- Jan 22, 2020
Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5
Wright, et al. J. Med. Chem., 2020, 63 (3), 1415-1433- Publication
- Sep 7, 2018
Replica Exchange with Solute Scaling: A more efficient version of Replica Exchange with Solute Tempering (REST2)
Wang, et al. J. Phys Chem B., 2011, 115(30), 9431-9438- Publication
- Sep 7, 2018
How To Deal with Multiple Binding Poses in Alchemical Relative Protein-Ligand Binding Free Energy Calculations
Kaus, et al. J. Chem. Theory Comput., 2015, 11(6), 2670-2679- Publication
- Sep 7, 2018
Application of Free Energy Perturbation for the Design of BACE1 Inhibitors
Ciordia, et al. J. Chem. Inf. Model., 2016, 56(9), 1856-1871- Publication
- Sep 7, 2018
Examining the Feasibility of Using Free Energy Perturbation (FEP+) in Predicting Protein Stability
Ford, et al. J. Chem. Inf. Model., 2017, 57(6), 1276-1285- Publication
- Sep 7, 2018
Relative binding affinity prediction of farnesoid X receptor in the D3R Grand Challenge 2 using FEP+
Schindler, et al. J Comput Aided Mol Des, 2017, (32)1, 254-272
Latest insights from Extrapolations blog
With FEP+, “The Experiment is the Limit.”
Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods
The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.
Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In
We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.
Training & Resources
Online certification courses
Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.
Free learning resources
Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.
Other Resources